老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Arcutis Biotherapeutics Inc.

13.53
+0.01500.11%
盘后：13.650.1200+0.89%19:53 EDT
成交量：198.76万
成交额：2,682.54万
市值：16.13亿
市盈率：-13.01
高：13.93
开：13.50
低：13.15
收：13.52
数据加载中...
总览公司新闻资讯公告
2021/11/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/07

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/07

持股变动声明

3/A [Amend] - Initial statement of beneficial ownership of securities
2021/10/05

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/07

重要事件披露

8-K - Current report
2021/08/05

重要事件披露

8-K - Current report
2021/08/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/14

重要事件披露

8-K - Current report
2021/05/12

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/06

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/04

重要事件披露

8-K - Current report
2021/04/23

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/26

重要事件披露

8-K - Current report
2021/02/16

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

重要事件披露

8-K - Current report
2021/02/16

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/09

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/02/09

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/02/08

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
更多